← Back to Search

Cancer Screening Interventions for Breast, Cervical, and Colorectal Cancer

N/A
Recruiting
Led By Shiraz I Mishra, MBBS, PhD
Research Sponsored by New Mexico Cancer Care Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Never had a mammogram OR not had a mammogram within the past 2 years
Inclusion Criteria: Breast Cancer Screening Intervention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months from end of the intervention
Awards & highlights

Study Summary

This trial is testing ways to improve cancer screening for breast, colorectal, and cervical cancers in American Indians, who are less likely to follow recommended guidelines.

Who is the study for?
This trial is for American Indian women aged 50-75 living in Zuni Pueblo, who are at average risk for breast cancer and have either never had a mammogram or haven't had one in the past two years. It aims to improve early screening adherence for breast, colorectal, and cervical cancers.Check my eligibility
What is being tested?
The study is testing multilevel intervention strategies designed to increase cancer screenings among American Indians. These interventions focus on enhancing prevention and control pathways specifically for breast, colorectal, and cervical cancers.See study design
What are the potential side effects?
Since this trial focuses on screening interventions rather than medications or treatments, there are no direct side effects from drugs being tested. However, participants may experience discomfort or anxiety related to the screening procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never had a mammogram or it's been over 2 years since my last one.
Select...
I am participating in a breast cancer screening program.
Select...
I am a woman aged between 50 and 75.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months from end of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6 months from end of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Completion of a Fecal Immunochemical Test kit to screen for colorectal cancer
Completion of a Mammogram exam to screen for breast cancer
Completion of a Pap Smear test to screen for cervical cancer
Secondary outcome measures
Change in Attitudes measured using the Health Behavior Survey
Change in Knowledge measured using the Health Behavior Survey
Change in Perceived Control measured using the Health Behavior Survey
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Breast, Colorectal, and Cervical Cancer ScreeningExperimental Treatment1 Intervention
The investigators will train Community Health Representatives (CHRs) in interactive group discussions techniques. CHRs will administer 1 session/week, lasting approximately 2 hours, and conducted among 12 men or women ages 21-75 per cluster. The CHRs will distribute the cancer-specific (i.e., breast, colorectal, and cervical) small media during the first session and refer to it during the course of the 4 sessions. During the sessions, the CHRs will function as a facilitator linking information with practical skills. At the end of the 4-week INT, participants will receive a voucher to present to a designated point-person at the health center who would schedule the screening for the age- and gender-specific cancers.
Group II: ControlActive Control1 Intervention
Historical control

Find a Location

Logistics

Travel, including flights, are covered

Your expenses for travel tickets for this trial will be reimbursed.

Who is running the clinical trial?

New Mexico Cancer Care AllianceLead Sponsor
70 Previous Clinical Trials
52,267 Total Patients Enrolled
4 Trials studying Breast Cancer
595 Patients Enrolled for Breast Cancer
National Institute of General Medical Sciences (NIGMS)NIH
266 Previous Clinical Trials
248,374 Total Patients Enrolled
5 Trials studying Breast Cancer
984 Patients Enrolled for Breast Cancer
Shiraz I Mishra, MBBS, PhDPrincipal InvestigatorUniversity of New Mexico School of Medicine
1 Previous Clinical Trials
22 Total Patients Enrolled

Media Library

Breast, Colorectal, and Cervical Cancer Screening Interventions Clinical Trial Eligibility Overview. Trial Name: NCT04259762 — N/A
Breast Cancer Research Study Groups: Breast, Colorectal, and Cervical Cancer Screening, Control
Breast Cancer Clinical Trial 2023: Breast, Colorectal, and Cervical Cancer Screening Interventions Highlights & Side Effects. Trial Name: NCT04259762 — N/A
Breast, Colorectal, and Cervical Cancer Screening Interventions 2023 Treatment Timeline for Medical Study. Trial Name: NCT04259762 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the eligibility requirements to join this clinical research endeavor?

"This medical research necessitates the recruitment of 120 females aged between 21 and 75 that have a diagnosis of breast cancer. Additionally, participants must pass these requirements: Breast Cancer Screening Intervention; Women Age 50-75; Normal Risk for Developing Breast Cancer; Not had an Imaging Exam in Last Two Years or Never Had One Before & Residing at Zuni Pueblo."

Answered by AI

How many individuals has this research endeavor enrolled thus far?

"Affirmative, clinicaltrials.gov indicates that this medical study is recruiting participants. The trial was initially published on June 1st 2021 and revised most recently on October 29th 2021. This experiment seeks 120 people from a single facility."

Answered by AI

What are the primary goals of this trial?

"The 6 month clinical trial will assess the effectiveness of a Mammogram exam in screening for breast cancer. Secondary objectives include quantifying changes to knowledge, perceived control and attitudes via the Health Behavior Survey."

Answered by AI

Is the age eligibility for this research limited to individuals under 70 years of age?

"This study has an upper age limit of 75 years old and a lower boundary set at 21."

Answered by AI

Is it still possible to apply for participation in this experiment?

"Affirmative. The information available on clinicaltrials.gov states that this medical experiment is currently recruiting participants, with the first listing being put up June 1st 2021 and most recently amended October 29th 2021. A total of 120 patients need to be enrolled at one site for it to move forward."

Answered by AI
~21 spots leftby Aug 2024